bioMérieux’s commitment to HIV testing started almost 30 years ago, at the very beginning of the epidemic. Our research teams developed one of the first screening tests available in 1985, following the discovery of the HIV virus.

Today, bioMérieux diagnostics play an essential role in HIV management, for screening, preventing mother-to-child transmission and improving patient care. We are committed to making innovation in HIV testing accessible to all types of healthcare settings and systems. Our objective is to improve patient care through HIV testing.


NUCLISENS<sup>® </sup> EASYQ®

Real-time NASBA Amplification Platform for fast, easy-to-read results

VIDAS® HIV panel

VIDAS<sup>®</sup> HIV panel

Advanced 4th generation assays for earlier diagnosis

Pioneering Diagnostics